Division of Speech & Swallowing Pathology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Department of Head & Neck Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, 400012, India.
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3011-3018. doi: 10.1007/s00405-020-06460-3. Epub 2020 Nov 9.
Laryngeal and hypopharyngeal carcinoma are among the common head and neck cancers causing considerable swallowing dysfunction. The functional status of the organ (larynx) is an important point of contention while considering the patients for organ preservation protocol.
The aim of this retrospective study was to assess the swallowing status in stage III/IV laryngeal and hypopharyngeal carcinoma and its influence on treatment decision. We evaluated all treatment naïve patients who were referred to the swallowing clinic in 2017 (Jan-Dec) for assessment of swallowing prior to treatment initiation.
One hundred patients satisfied the eligibility criteria and were included in the study. The site and stage of laryngeal and hypopharyngeal cancer cases were almost equal in number. Their median age was 58 years. Fiberoptic endoscopic evaluation of swallowing (FEES) was done in all patients. 30% of the patients only had swallowing difficulties. Only advanced T-stage (p = 0.04) had an influence on the pretreatment swallowing status. Thirty-seven patients required nasogastric tube (NGT) for feeding. By 2 month post-treatment completion, most patients on NGT could resume oral feeding.
Pretreatment swallowing assessment alone did not significantly seem to influence our decisions for organ preservation treatment. However, patients with aspiration could be identified and managed appropriately. Most patients on NGT could resume oral feeds post-treatment completion.
喉癌和下咽癌是常见的头颈部癌症之一,会导致相当程度的吞咽功能障碍。在考虑为患者保留器官的治疗方案时,器官(喉)的功能状态是一个重要的争议点。
本回顾性研究旨在评估 III/IV 期喉癌和下咽癌患者的吞咽状况及其对治疗决策的影响。我们评估了 2017 年(1 月至 12 月)在治疗开始前因吞咽问题而被转介到吞咽诊所的所有未经治疗的患者。
符合入选标准的 100 例患者被纳入研究。喉和下咽癌病例的部位和分期几乎相等。他们的中位年龄为 58 岁。所有患者均进行了纤维内镜吞咽评估(FEES)。只有 30%的患者存在吞咽困难。只有晚期 T 分期(p=0.04)对治疗前的吞咽状况有影响。37 例患者需要经鼻胃管(NGT)喂养。治疗完成后 2 个月,大多数接受 NGT 的患者可以恢复经口进食。
单独进行治疗前吞咽评估似乎并没有显著影响我们保留器官的治疗决策。然而,可以识别出有吸入风险的患者,并进行适当的管理。大多数接受 NGT 的患者在治疗完成后可以恢复经口进食。